11630 SW 97 Street, Miami, Florida 33176, US
Advertising Driven Press Release Distribution
Advertising Driven Press Release Distribution
The Bacillus Coagulans Market size is estimated to reach $126.3 million by 2027. Furthermore, it is poised to grow at a CAGR of 7.7% over the forecast period of 2022-2027. Bacillus coagulans is a category of pre-biotic and is mostly conferred as Lactobacillus sporogenes. The following category of pre-biotic can produce lactic acid but is different from the overall Lactobacillus. The coagulans can produce spores during their reproductive life cycle, which is a key differentiation between other pre-biotics and this. The following can go dormant in cases it faces a harsh environment, while the others may not just survive those conditions. Hence, the following strain of bacteria can sail through the harsh conditions of one’s stomach. The beneficial aspects of the following ingredient of the bacterial class have made it a key aspect of a variety of dairy and food items. Moreover, they are used in fermented meat, baby foods, fruit juices, and a variety of cereal classes. Furthermore, Bacillus coagulans can be found in natural food sources such as sauerkraut, kimchi, and yogurt. However, one can easily find it in the format of supplements as well. The growing demand from the supplemental format and from infant nutrition along with the technological development are some of the key factors driving the Bacillus Coagulans Industry forward in the projected period of 2022-2027.
Bacillus Coagulans Market Segmentation Analysis- By Application
The bacillus coagulans market based on the application can be further segmented into non-dairy, dairy, cereal, infant nutrition, and others. Infant Nutrition held a dominant market share in the year 2021. It is owing to the rising number of gut health problems being actively faced by newborns or toddlers. Gastrointestinal problems taken by infectious routes are growing more prevalent; around 3-5 billion episodes of pediatric gastrointestinal disorders would occur globally in kids and are extremely common in children below the age of 15 months. Hence, by using Bacillus coagulans in infant nutrition, the overall gut health can be improved, which in turn will support better immune function and stool movements.
The non-dairy segment is estimated to be the fastest-growing, with a CAGR of 8.4% over the forecast period of 2022-2027. It is owing to the ready adoption of dairy-free products in regular diets. As per the Plant-based association, a 20.1% increase in the “milk category” was also the highest contributing attribute in revenue collection. Moreover, cases of digestive cancers are rising, thereby supplementing the growth of the bacillus coagulans market.
Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=502794
Report Price: $ 4500 (Single User License)
Bacillus Coagulans Market Segmentation Analysis- By End-Users
The bacillus coagulans market based on end-users can be further segmented into – Food and Beverages Industries, Cosmeceutical Manufacturers, Nutraceutical Manufacturers, Pharmaceutical Manufacturers, Animal Husbandry, and Others. The food and beverage industry held a dominant market share in the year 2021. It is owing to the use of the following ingredient in a variety of beverage applications. For example, cereals are now widely incorporating bacillus coagulans in their product launches. Kellogg’s and other giants have launched products that contains the following ingredient, as it is easy to formulate and implement. Additionally, the pH value to sustain till 4.5 allows it to move past the digestive tract acids, thereby making a favorable bacterial.
Moreover, the nutraceutical manufacturers segment is estimated to be the fastest-growing, with a CAGR of 8.5% over the forecast period of 2022-2027. It is owing to the uprising of the following industry and the ease by which they can be obtained in terms of supplements. Manufacturers such as Thorne have had a product only offering the following ingredients, as it promotes GI function and bowel regularity. The following product contains 133mg of the said bacteria.
Bacillus Coagulans Market Segmentation Analysis- By Geography
The Bacillus Coagulans Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. Europe held a dominant market share of 36% as compared to the other regions in 2021. It is owing to the usage of the following ingredient across the various application. For example, around 21% of the population is aged above 65+, thereby the demand for the following ingredient is high for controlling IBD and other ailments. IBD affects around 2.5-3 million people in the region. Secondly, bacillus coagulans are an extremely important ingredient for livestock management and gut health management; owing to the high input of livestock exported from the following region, the bacillus coagulans market held a dominant part and will continue to do so.
However, Asia-Pacific is set to offer lucrative growth opportunities to marketers. It is owing to the rising inclination of having healthy nutrition throughout the day. Additionally, the working proportion of women in the region is rising, thereby making them use infant nutrition products. The following will be the key driver for the market in the coming times ahead.
Bacillus Coagulans Market Drivers
An increment in the global prevalence of functional gastrointestinal disorders has substantially aided the market growth of bacillus coagulans
Functional Gastrointestinal Disorders are growing more prevalent across various demographics across the globe. The following can include acid reflux, heartburn, constipation, and various other symptoms, which can be readily cured with the help of Bacillus coagulans, as concluded by researchers. Moreover, with the use of the following, the overall immune system can be benefitted. As per a study published, for every ten adults in the world, around four have FGIDs. Moreover, demographics play a vital role in determining the average. Additionally, people suffering from IBD were given the following supplement and were compared with the placebo group, and each showed improvement as compared with the placebo. Lastly, the use of bacillus coagulans helped people in relieving intestinal gas. Owing to such benefits, the following is being actively used in various applications.
The non-dairy food applications have readily aided the growth of the Bacillus Coagulans Market
Prebiotic foods obtained from sustainable practices have been a key distinguishing factor for the end-consumers. Owing to such trends, the veganism trend took everyone by surprise, as often the products are obtained by fair practices. Thereby, prebiotic food origination from the vegan source has aided the market growth, especially in the sector of non-dairy food items or dairy alternatives. Owing to its high heat-resistant properties and excellent life in harsh conditions, they are increasingly preferred. For example, the pH at which bacillus coagulans can survive is between 5.5-6.5, and the optimum growth temperature was found close to 35-50 degrees. Lastly, around $7billion of revenue was collected from food products made from dairy alternatives, which is around 30% higher than the previous year has further substantiated the demand for the market.
Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=502794
Bacillus Coagulans Market Challenges
Limited research and potential health risk pose a unique market challenge
Prebiotics has been a topic of research for a decade or more. However, limited research pertaining to bacillus coagulans has taken place, thereby leaving a space for ambiguity and fear amongst the end consumers. Additionally, certain research has come along which governs that bacillus coagulans were found in patients suffering from leukemia, lymphoma, and breast cancer. As per WHO, leukemia is the tenth most common cancer diagnosed each year, while 2.3 million people were diagnosed with breast cancer in the year 2020. An increasing number of cancer patients has receded the growth of the market.
Bacillus Coagulans Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Bacillus Coagulans Market. Bacillus Coagulans top 10 companies include:
Mitsubishi Chemical Foods Corporation,
Ganeden,
Nebraska Cultures,
UAS Laboratories,
Sabinsa Corporation,
Syngen Biotech,
Sanzyme,
Microbax,
Mystical Biotech Pvt. Ltd,
Aumgene Bioscience
Recent Developments
In January 2021, Biochem received EU Approval for Techno Spore, a new bacillus coagulans probiotics for animals. It can help in delivering better gut health management for weak piglets and ornamental birds. In contrast to its other pro-biotics in the market, the following only contains one powerful bacterial strain or DSM 32016 of Bacillus Coagulans. Overall well-being, daily weight gain and feed conversion ratio, intestinal health, and food safety, immune defense are some of the plausible benefits observed in trials.
In June 2020, Chr. Hansen acquired UAS Laboratories for $530 million. The latter focuses on providing clinically documented prebiotics. Additionally, the acquired company has six trademarked probiotic strains which benefit digestive disorders, immune stimulation, infant prebiotics, and weight management. Lastly, Probiotics under the company’s ProDura brand of Bacillus coagulans provide digestive and immune support, according to UAS Labs, and they have been shown to work in food, gummy, and extrusion applications where thermal stability in a probiotic organism is required.
In February 2020, Bacillus Coagulans SNZ 1969 received FDA GRAS approval for its use in infant formula nutrition. The Sanzyme Biologics had applied for the approval of GRAS and received from the FDA. Moreover, spore preparation is permitted for use within the infant formula ingredient up to the levels of 2×108 colony forming units per 100 ml. Moreover, the company plans to benefit millions of babies across the world with its gut health solution.
Direct Purchase @ https://www.industryarc.com/purchasereport.php?id=502794
Key Takeaways
Geographically, Europe’s Bacillus Coagulans Market held a dominant market share in the year 2021. It is attributed to the rising inclination of the given demographic to adopt healthy bacteria in their daily diets. Additionally, the following ingredient is consumed across the age groups. However, Asia-Pacific is set to offer lucrative growth opportunities owing to digital captivation and increment in their functional health knowledge pertaining to the good bacterium. Additionally, the disease pertaining to gut health will further propel the growth in the region.
Owing to medicinal benefits from the bacillus coagulans the market is driven at a steadfast pace across various applications. However, regulatory blockages and low awareness pertaining to such products have dampened the market growth.
A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Bacillus Coagulans Market Report.
Related Reports:
A. Gastrointestinal Therapeutics Market
https://www.industryarc.com/Research/Gastrointestinal-Therapeutics-Market-Research-502755
B. Clinical Information System Market
https://www.industryarc.com/Report/15554/clinical-information-system-market.html
For more Lifesciences and Healthcare Market reports, please click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.
For exclusive content regarding the latest trends in the world of Press Release distribution.
